P. Pattengale

发表

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

P. Leder, W. Muller, William J. Muller, 1988, Cell.

Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis

H. Fan, B. Brightman, P. Pattengale, 1986, Journal of virology.

T-lymphocyte clones from leprosy skin lesions.

B. Bloom, R. Modlin, T. Rea, 1986, Leprosy review.

Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

C. Taylor, P. Pattengale, 1983, The American journal of pathology.

A color atlas of hematopoietic pathology of mice.

J. Ward, C. Frith, P. Pattengale, 1985 .

Platelet-derived growth factor concentrations in platelet-poor plasma and urine from patients with myeloproliferative disorders.

R. Carmel, P. Pattengale, G. Gersuk, 1989, Blood.

BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.

V. Kaartinen, J. Voncken, N. Heisterkamp, 1995, Blood.

Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.

J. Voncken, N. Heisterkamp, J. Groffen, 2000, Blood.

Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.

J. Voncken, N. Heisterkamp, J. Groffen, 2000 .

Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties

H. Fan, R. Hanecak, P. Pattengale, 1988, Journal of virology.

Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

P. Leder, E. Schmidt, L. Weir, 1988, Proceedings of the National Academy of Sciences of the United States of America.

A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice

P. Leder, M. Nussenzweig, E. Schmidt, 1988, Nature.

Multiple tumor types appear in a transgenic mouse with the ras oncogene.

R. Cardiff, P. Leder, A. Kuo, 1993, The American journal of pathology.

The int‐2 gene product acts as an epithelial growth factor in transgenic mice.

P. Leder, G. Peters, W. Muller, 1990, The EMBO journal.

Comparison of three recombinant murine leukemia viruses carrying the v‐src oncogene of avian sarcoma virus: Differences in in vitro transformation and in vivo pathogenicity

H. Fan, W. Lee, P. Pattengale, 1988, Molecular carcinogenesis.

Generation of a recombinant Moloney murine leukemia virus carrying the v-src gene of avian sarcoma virus: transformation in vitro and pathogenesis in vivo

H. Fan, B. Davis, P. Pattengale, 1985, Journal of virology.

B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus.

P. Gerber, P. Pattengale, R. W. Smith, 1974, Journal of the National Cancer Institute.

Relationship of Immune Deficiency and Oncogenic Viruses to Malignant B Cell Lymphomas: Mouse and Man

P. Pattengale, 1984 .

Lymphohematopoietic and other malignant neoplasms occurring spontaneously in transgenic mice carrying and expressing MTV/myc fusion genes.

P. Leder, A. Kuo, P. Pattengale, 1986, Current topics in microbiology and immunology.

Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions

B. Bloom, R. Modlin, V. Mehra, 1986, Nature.

Selective transformation of B lymphocytes by E.B. virus.

P. Gerber, P. Pattengale, R. W. Smith, 1973, Lancet.

A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.

T. Lincoln, C. Taylor, J. Parker, 1978, The American journal of pathology.

Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

F. Behm, A. Look, S. Morris, 1997, Blood.

Humanbcr-abl gene has a lethal effect on embryogenesis

D. Kioussis, G. Jenster, N. Heisterkamp, 1991, Transgenic Research.

Restricted oncogenicity of BCR/ABL p190 in transgenic mice.

M. Greaves, J. Voncken, N. Heisterkamp, 1992, Cancer research.

Natural killer (NK) cell immunodeficiency in patients with chronic myelogenous leukemia

A. Bakke, P. Pattengale, A. Bakke, 1987, Cancer Immunology, Immunotherapy.

Childhood lymphoma‐leukemia. I. correlation of morphology and immunological studies

T. Lincoln, J. Quinn, C. Taylor, 1978, Cancer.

Biological characterization of uncleavable plasma membrane-anchored human macrophage colony-stimulating factor.

P. Pattengale, Y. L. Wang, V. Shahbazian, 2000, Biochemical and biophysical research communications.

Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity.

J. Parker, R. Lukes, P. Rosen, 1978, Annals of internal medicine.

Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.

H. Fan, H. Chute, P. Pattengale, 1988, Virology.

Subcutaneous Panniculitis-Like T-Cell Lymphoma in Two Pediatric Patients: An HIV-Positive Adolescent and a 4-Month-Old Infant

J. Church, P. Gaynon, D. Cassarino, 2013, Fetal and pediatric pathology.

hemophagocytic lymphohistiocytosis and kikuchifujimoto disease associated with mumps in a previously vaccinated child a case report and review of the literature

P. Pattengale, 2017 .

Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice.

F. Behm, A. Look, K. Pulford, 1997, Blood.

Immunopathology of B-cell lymphomas induced in C57BL/6 mice by dualtropic murine leukemia virus (MuLV).

M. Haas, C. Taylor, P. Pattengale, 1982, The American journal of pathology.

Lysis of human B‐lymphocyte‐derived lymphoma/leukemia cells of established cell lines by interferon‐activated natural killer (NK) cells

H. Wigzell, K. Nilsson, M. Gidlund, 1981, International journal of cancer.

Morphologic and cytochemical comparison of human lymphoblastoid T-cell and B-cell lines: light and electron microscopy.

C. Taylor, J. Parker, I. Royston, 1978, Journal of the National Cancer Institute.

Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor.

O. Witte, D. Kohn, R. Stripecke, 1998, Human gene therapy.

Lymphoproliferative Diseases: Pathogenesis, Diagnosis, Therapy

R. Lukes, P. Pattengale, C. Taylor, 1985, Developments in Oncology.

Natural killer cells kill tumour cells at a given stage of differentiation

M. Jansson, H. Wigzell, K. Nilsson, 1981, Nature.

Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

J. Downing, P. Pandolfi, R. M. Simpson, 2002, Blood.

Tumours of the lymphohaematopoietic system.

P. Pattengale, 1994, IARC scientific publications.

Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus

H. Fan, R. Hanecak, P. Pattengale, 1991, Journal of virology.

Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro

H. Fan, H. Chute, P. Pattengale, 1986, Journal of virology.

A sensitive LC-MS/MS method for the quantification of urinary 8-iso-prostaglandin F2α (8-iso-PGF2α) including pediatric reference interval.

J. Dien Bard, M. O'gorman, P. Pattengale, 2016, Clinica chimica acta; international journal of clinical chemistry.

Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers.

E. Perlin, P. Pattengale, R. W. Smith, 1974, The New England journal of medicine.

Lysis of fresh human B‐lymphocyte‐derived leukemia cells by interferon‐activated natural killer (NK) cells

H. Wigzell, K. Nilsson, M. Gidlund, 1982, International journal of cancer.

Contributions of recent research to the classification of spontaneous lymphoid cell neoplasms in mice.

C. Frith, P. Pattengale, C. H. Frith, 1986, Critical reviews in toxicology.

Immunogenetic analysis of bone marrow aspirates in patients with non‐hodgkin lymphomas

P. Pattengale, L. Pinter-Brown, E. Hu, 1990, American journal of hematology.

Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin‐2 production by t‐helper and natural killer cells

P. Pattengale, N. Casteel, W. Chang, 1989, International journal of cancer.

A Rapid High-Performance LC-MS/MS Method for Therapeutic Drug Monitoring of Voriconazole, Posaconazole, Fluconazole, and Itraconazole in Human Serum.

M. O'gorman, P. Pattengale, Xiaowei Fu, 2017, The journal of applied laboratory medicine.

Simple, Fast, and Simultaneous Detection of Plasma Total Homocysteine, Methylmalonic Acid, Methionine, and 2-Methylcitric Acid Using Liquid Chromatography and Mass Spectrometry (LC/MS/MS).

P. Pattengale, P. Chan, Xiaowei Fu, 2013, JIMD reports.

Bethesda proposals for classification of lymphoid neoplasms in mice.

N. Harris, E. Jaffe, J. Ward, 2002, Blood.

Suppressor T lymphocytes from lepromatous leprosy skin lesions.

B. Bloom, R. Modlin, V. Mehra, 1986, Journal of immunology.

Sites of synthesis of murine RNA tumor virus (oncornavirus) group-specific antigens.

G. Thorbecke, P. Pattengale, H. Ikeda, 1974, Cancer research.

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo

P. Leder, E. Sinn, P. Pattengale, 1987, Cell.

Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development

P. Leder, A. Kuo, P. Pattengale, 1986, Cell.

Acute leukaemia in bcr/abl transgenic mice

G. Jenster, N. Heisterkamp, J. Groffen, 1990, Nature.

Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice.

J. Voncken, N. Heisterkamp, J. Groffen, 1992, Blood.

Commentary Role of lnterleukin-6 in the Pathogenesis of Murine Plasmacytoma and Human Multiple Myeloma

P. Pattengale, 2007 .

Constitutive HOXA5 expression inhibits erythropoiesis and increases myelopoiesis from human hematopoietic progenitors.

P. Malik, J. Gasson, G. Crooks, 1999, Blood.

BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl

V. Kaartinen, N. Heisterkamp, J. Groffen, 2002, Oncogene.

Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice.

V. Kaartinen, N. Heisterkamp, J. Groffen, 2001, Cancer research.

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes

P. Leder, P. Pattengale, T. Stewart, 1984, Cell.

Increased neutrophil respiratory burst in bcr-null mutants

V. Kaartinen, J. Voncken, N. Heisterkamp, 1995, Cell.

Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice

P. Doherty, M. Brown, D. Topham, 1998, Nature Medicine.

The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice.

J. Voncken, N. Heisterkamp, J. Groffen, 2001, International journal of molecular medicine.

Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

M. Hsiao, M. Haas, J. Yeargin, 1994, The American journal of pathology.

Structural Requirements for the Ectodomain Cleavage of Human Cell Surface Macrophage Colony-stimulating Factor*

Ping Deng, P. Pattengale, C. W. Rettenmier, 1996, The Journal of Biological Chemistry.

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia.

H. Shimada, D. Kohn, R. Stripecke, 1999, Human gene therapy.

Murine interleukin-4 displays potent anti-tumor activity in vivo

P. Leder, R. Tepper, P. Pattengale, 1989, Cell.

Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma.

D. Hinton, R. Maxson, P. Pattengale, 1999, Blood.

Differentiation in vitro of a leukemia virus-induced B-cell lymphoma into macrophages

H. Fan, R. Hanecak, P. Pattengale, 1989, Molecular and cellular biology.

Animal models of human disease. Pathology and molecular biology of spontaneous neoplasms occurring in transgenic mice carrying and expressing activated cellular oncogenes.

P. Leder, E. Schmidt, E. Sinn, 1989, The American journal of pathology.

Characterization of lymphoid tumors induced by a recombinant murine retrovirus carrying the avian v-myc oncogene. Identification of novel (B-lymphoid) tumors in the thymus.

K. Chandy, R. Spencer, B. Brightman, 1988, Journal of immunology.

Classification of Mouse Lymphoid Cell Neoplasms

P. Pattengale, 1990 .

Immunomorphologic classification of spontaneous lymphoid cell neoplasms occurring in female BALB/c mice.

C. Frith, P. Pattengale, 1983, Journal of the National Cancer Institute.

An Adolescent with Increased Plasma Methylmalonic Acid and Total Homocysteine.

M. O'gorman, P. Pattengale, W. Mitchell, 2017, Clinical chemistry.

Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and productio

P. Pattengale, W. Chang, M. Hsiao, 1991, Natural Immunity and Cell Growth Regulation.

Natural killer activity in (C57BL/6 × DBA/2)F1 hybrids undergoing acute and chronic graft‐vs.‐host reaction

U. Ramstedt, H. Wigzell, M. Gidlund, 1983, European journal of immunology.

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

P. Davis, R. Sposto, S. Wolden, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombination activating gene-1 (RAG-1) expression in all differentiation stages of B-lineage precursor acute lymphoblastic leukemia.

K. Weinberg, P. Pattengale, T. Umiel, 1993, Leukemia.

CHARACTERIZATION OF NK CELLS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA1

P. Pattengale, Y. Fujimiya, 1985 .

Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.

H. Fan, P. Pattengale, E. Suchman, 1995, The Journal of general virology.

Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemia

G. Raca, C. Fu, P. Pattengale, 2016, Leukemia research reports.

Multiparameter analyses of spontaneous nonthymic lymphomas occurring in NFS/N mice congenic for ecotropic murine leukemia viruses.

H. Morse, P. Pattengale, J. Hartley, 1985, The American journal of pathology.

Establishment and characterization of a human mixed-lineage, T-lymphoid/myeloid cell line (USP-91).

H. Shimada, S. Siegel, P. Pattengale, 1993, Blood.

Effect of low levels of nitrogen dioxide inhalation on endogenous retrovirus gene expression.

R. Sherwin, P. Pattengale, P. Roy‐Burman, 1982, Experimental and molecular pathology.

Quantification of glypican 3, β‐catenin and claudin‐1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution

D. Parham, Larry L. Wang, Shengmei Zhou, 2015, Histopathology.

Direct tissue visualization of normal cross-reacting antigen in neoplastic granulocytes.

E. Engvall, E. Ruoslahti, C. Taylor, 1980, American journal of clinical pathology.

Multiple factors determine the selection of the ectodomain cleavage site of human cell surface macrophage colony-stimulating factor.

P. Pattengale, Y. L. Wang, Y. Haga, 1998, Biochemistry.

The role of individual cysteine residues in the processing, structure, and function of human macrophage colony-stimulating factor.

P. Pattengale, C. W. Rettenmier, Y. L. Wang, 1996, Biochemical and biophysical research communications.

Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.

H. Fan, L. Bundy, J. Portis, 1995, Virology.

Animal Models of Lymphoid Cell Neoplasia

P. Pattengale, 1985 .

Stabilization of Sheep Red Blood Cell (E) Rosettes with High Molecular Weight Compounds

P. Reichelderfer, P. Pattengale, 1975 .

Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.

A. Yu, P. Pattengale, C. Sundstrom, 1983, Natural immunity and cell growth regulation.

Dissemination and tissue invasiveness in murine acute leukemia associated with acquisition of p53 mutation and loss of wild‐type p53

M. Haas, J. Yeargin, P. Pattengale, 1995, Molecular carcinogenesis.

Follicular Center Cell Lymphoma, Mouse

P. Pattengale, 1990 .

Immunohistochemistry, Lymphoid Cells, Mouse

P. Pattengale, 1990 .

Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases.

C. Taylor, P. Pattengale, C. Pegalow, 1981, The American journal of pediatric hematology/oncology.

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry.

H. Ochs, G. Vawter, J. Greally, 1982, The American journal of medicine.

B-Cell Lymphomas Induced in C57BL/6 Mice

P. Pattengale, C. Taylor, P. Twomey, 2007 .

Selective immunodeficiency and malignant lymphoma of the central nervous system

R. Davis, D. Rawlinson, P. Pattengale, 1979, Acta Neuropathologica.

Ganglioside gm2 as a target structure recognized by human natural killer cells

P. Pattengale, S. Golub, I. Ando, 1987 .